MeSH term
Frequency | Condition_Probility | Alleles | 6 | 0.0 |
Comparative Study | 4 | 0.0 |
DNA Primers | 2 | 0.0 |
Gene Frequency | 6 | 0.0 |
Genotype | 6 | 0.0 |
Humans | 31 | 0.0 |
Research Support, Non-U.S. Gov't | 14 | 0.0 |
Base Sequence | 5 | 0.0 |
Kell Blood-Group System/*genetics/immunology | 2 | 100.0 |
Phenotype | 10 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 5 | 0.0 |
Adolescent | 5 | 0.0 |
Adult | 9 | 0.0 |
Capsules | 2 | 4.0 |
Male | 17 | 0.0 |
Kell Blood-Group System/*genetics | 6 | 54.0 |
Point Mutation | 4 | 0.0 |
ABO Blood-Group System/genetics | 3 | 7.0 |
Blood Group Antigens/*genetics | 7 | 6.0 |
Female | 13 | 0.0 |
Kell Blood-Group System/genetics | 2 | 28.0 |
Kidd Blood-Group System/genetics | 2 | 40.0 |
Animals | 3 | 0.0 |
Polymorphism, Genetic | 7 | 0.0 |
Structure-Activity Relationship | 2 | 0.0 |
English Abstract | 4 | 0.0 |
Middle Aged | 8 | 0.0 |
Probability | 2 | 0.0 |
Amino Acid Sequence | 5 | 0.0 |
Molecular Sequence Data | 6 | 0.0 |
Pedigree | 3 | 0.0 |
African Continental Ancestry Group/*genetics | 2 | 0.0 |
Aged | 3 | 0.0 |
Child | 3 | 0.0 |
Child, Preschool | 2 | 0.0 |
Ethnic Groups/*genetics | 2 | 1.0 |
Infant, Newborn | 3 | 0.0 |
Marriage | 2 | 8.0 |
Pregnancy | 3 | 0.0 |
*Polymorphism, Genetic | 3 | 0.0 |
Polymerase Chain Reaction | 3 | 0.0 |
Polymorphism, Restriction Fragment Length | 3 | 0.0 |
Blood Proteins/*genetics | 2 | 1.0 |
Exons | 2 | 0.0 |
Genes, Structural | 2 | 0.0 |
Genetic Markers | 2 | 0.0 |
Drug Interactions | 2 | 0.0 |
Kinetics | 5 | 0.0 |
Liver/*metabolism | 2 | 0.0 |
Administration, Oral | 2 | 0.0 |
